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JEFFERY P. LANGER: Well, good morning everyone. [T]hank you all for 
joining us at the IIPCC’s third annual event here at our nation’s capital. My name 
is Jeffery Langer, I am an executive member with the IIPCC. Let me start by 
thanking our sponsors, the gentlemen from TechInsights. Once again, 
TechInsights has offered us financial support for this and it really is the lifeblood 
for our work here in the nation’s capital. This is the third year they have done it. 
Unfortunately, Art Monk, who is a close colleague of IIPCC, is unable to make 
it this year, but he sent this gentleman and his proxy so thank you very much. I 
really appreciate all the work that you guys do and all the support you have given 
us over the years. I would also like to recognize the Catholic University of 
America, the law school, this is the second year [that] we will be publishing 
transcripts of the proceedings that go on here today. Next, I would also like to 
thank PBEC, which is a long-term collaborator with us at the IIPCC. For those 
of you that do [not know] PBEC, this is the Pacific Basin Economic Council 
based out of Hong Kong. IIPCC actually started in Hong Kong and there has 
been long-term collaboration and work with that organization. So, we thank 
them. And finally, I would like to sincerely thank Senator Chris Coons and his 
staff, they have helped us every year we have come here for this program, with 
logistics and preparing rooms. 
For those of you that are not familiar with the IIPCC, this is short for the 
International Intellectual Property Commercialization Council. It was founded 
in 2013 and it is a global, non-profit, non-partisan organization, really focused 
on driving conversations about innovation and commercialization of innovation. 
Of course, at the cornerstone of that is intellectual property, but we really try and 
look at this as a holistic system and seek to find ways for different parties that 
are involved in this to work together and develop and commercialize this 
innovation. The key of this is really human growth and development. Ideally, 
this commercialization and innovation takes place in a way to improve the living 
standard in societies worldwide. 
So, just a couple of notes on IIPCC, since our founding in 2013, we have 
expanded rapidly. [While we have many] international offices, I would like to 
highlight some of our newest members: the people in Brisbane, they just started 
this year; [the people in] the Tokyo office, which was just recently established; 
[and the members in] Osaka. Continuing with our theme of innovation, [I would 
also like to recognize] the move by the previous IIPCC Hong Kong that is now 
going be adopting the greater bay area chapter that will incorporate Southern 
China, Hong Kong, Macau and other countries in that area. If I could also note 
too, there are a number of IIPCC folks that have come in from international 
chapters today. We have representatives from Hong Kong, from the Toronto 
chapter, and in the U.S., we have folks here from New York, as well as San Jose. 
We also have somebody here from Korea. We also benefit from a fantastic board 
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and a number of people that work very hard behind the scenes to help guide the 
IIPCC’s mission. We are very fortunate to have a number of the people on our 
board [here] today including Professor Carl Schramm, who will be speaking on 
one of the later panels. [We also have] Judge Randall Rader, who many people 
in this room know, who will be giving the closing remarks, and Johnson Kong 
is here from Hong Kong. Unfortunately, David Capos was supposed to be here 
as well to give opening remarks, but he has been called away to something else 
so I will be taking over that role. 
So, for some opening comments, I was really thinking about what we were 
thinking about when we were conceiving this conference. For those of you that 
have attended our conferences in the past, we have been much more focused on 
intellectual property laws specifically, and our panels have really focused on 
U.S. [laws and what they] look like in comparison to rules and regulations in 
other parts of the world. [There has] been much more of a legal focus. This year, 
we really wanted to take a step back and start to talk about innovation in a much 
more holistic manner, and while IP is a cornerstone for a lot of this, the 
innovation and commercialization of that innovation are other parts of the 
ecosystem that also require some attention. One of the things that drove this 
thinking for me was a conversation I recently had with a former classmate. We 
were talking about the speed of innovation and how that has really [been] 
altering what innovation looks like. As background, he is working for Governor 
Kasich’s office in the workforce transformation office, where they are looking 
at what educational policy should look like for Ohio as we are moving through 
all these dramatic technical changes. You know, what is going to be the impact 
of autonomous vehicles as those start to ripple through the commercial 
ecosystem, and how are we going to train people in their K–12 years and then in 
their college years for these on-going and increasingly rapid transformations to 
technology? 
I think as humans too, we are not particularly good at keeping in mind how 
fast some of these changes are taking place. If we think about—and I know this 
is two-year-old data—but if we talk about mass adoption of airlines, this was 
only really sixty-eight years ago; telephones, only fifty years ago; radio, thirty-
eight years ago; television, twenty-two years ago. Then if we start looking at 
Pokémon GO and Angry Birds, which really involve only a two-year-old 
technology, these are very commercial, consumer-oriented things [that have 
been widely adopted very quickly]. So, as the panels are coming up today, I 
think it is critical that we think about innovation, the speed of it, and how that is 
going to change while we are considering the state we are in today. So, with that, 
let me introduce the first panel, and Everardo, I will let you introduce the 
panelists. 
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EVERARDO RUIZ: My name is Everardo Ruiz and I am actually in IIPCC 
Seattle, so I took a nice red-eye [flight] to get here. At the same time, the reason 
I did that was because it just seemed like it was important. There is a lot of 
discussion around innovation with almost zero facts presented, right? “Oh, it 
happens this way. It does not happen this way. It happens this way.” No data, 
right? Well it turns out, data does exist, and it is studied. So really, this panel is 
boots on the ground and it describes this kind of half-life of technology 
decreasing so rapidly and things just happening so quickly in this internet era 
that we live in. How do we actually innovate? How does it actually occur? Why 
does it happen in the United States? What works? What might be some 
challenges? How do you make it sustainable so that it is here, because it can 
happen all over the world, right? So [this idea and these questions are really] 
what drew me to this theme of boots on the ground. 
I would say there are really three groups of speakers. One is focused on 
realities. What does the data say when questions are raised? We have a speaker 
who will be handling that from Georgetown. We will also be focusing on what 
the government is doing to promote innovation. What does the view look like if 
you are actually sitting inside the National Institute of Standards and Technology 
(“NIST”)? [NIST] is something which a lot of people do not really understand, 
but it has a huge reach; it is not just looking for magnetic monoparticles or 
something like that. I mean it really is important, as is the Small Business 
Administration (“SBA”). Finally, the other way to get the view of the war is to 
go talk to the soldiers, to the people who are actually fighting it. So, we have 
several speakers from their specific companies and [you will see the current 
world is] very interdisciplinary. It is a very different world than it was back when 
the airplane was invented. So, how does that change things, right? Again, [we 
will look at] what is working, what is not working. Then, we will have a 
[question and answer portion] at the end to take questions since time is short. 
This will allow [the questions] to be pooled and for us to maybe get some 
interaction between the speakers. 
First, let us talk about innovation realities. From Georgetown University Law 
Center, we have Neel Sukhatme, who is an associate professor of law [with a] 
JD cum laude from Harvard Law, a PhD in economics from Princeton, [and who 
is a] Thomas Alva Edison Visiting Fellow at the U.S. Patent and Trademark 
Office. So, data, he has. Let us go ahead and invite him up to the platform for 
some third-party observations. 
PROFESSOR NEEL SUKHATME: Thank you Everardo. It is a pleasure to 
be here. My name is Neel Sukhatme. As Everardo mentioned, I am a professor 
at Georgetown Law where I teach patent law, corporate finance, and law in 
economics, among other subjects. I have been interested in patents and 
innovation for a long time. I started off my career as a patent prosecutor right 
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after I earned my degree in computer engineering. After that, I went to law 
school and then practiced as a patent litigator and also as a federal court clerk. I 
was really interested in trying to do empirical analysis in this area, so then I 
decided to go back [to school] and [earn] my PhD in economics, where my 
dissertation research focused on the economics of innovation and patenting. I 
am also a co-founder of a music technology start-up company, Spindrop, so I 
have worked on patent issues on that end [as] an entrepreneur and I have just 
started at the U.S. Patent and Trademark Office (“USPTO”) as a Thomas Edison 
Fellow. So obviously my comments here are not in my capacity as a fellow at 
the USPTO, but I am planning on doing research related to the Patent Trial and 
Appeal Board (“PTAB”) over there. Finally, my wife is in the pharmaceutical 
industry, so I get a little bit of a sense of where the patent issues are in that 
[arena] as well. 
I have been really fortunate to be able to look at patent policy and intellectual 
property rules in a lot of different settings, and I am fortunate to be at 
Georgetown, which is building the leading law and technology center and hiring 
some of the best people in the world on these topics. But today, I want to talk 
about something that is central to my research, and that is the role of data in 
patent policy analysis. So, when we talk about patents and innovation, regardless 
of your political stripes, there are a lot of common goals I think we all share. We 
all want to promote innovation, right? This is important for growth; we think 
that is important. All else being equal, we also want to increase access and 
affordability of technologies for consumers. We want more people to get access 
to technologies that are created because that is the whole goal. 
But how do we get there? There are a lot of questions that have an empirical 
foundation but not so much [the] kind of facts as to what is actually going on. 
So, some questions might be: Do longer patent terms actually incentivize more 
innovation, or do they just create what we call dead weight loss1 or monopoly 
cost?2 Which industries care the most about patent protection? We have ideas as 
to who we think cares about patents, namely pharmaceuticals and biotech 
companies, but is our conventional wisdom accurate? Is there a way of actually 
testing this? What do consumers and the general public, think about patents? Do 
we have any sense of what it means to them when you show them that a product 
                                                          
 1 Deadweight Loss, INVESTOPEDIA, https://www.investopedia.com/terms/d/ 
deadweightloss.asp (last updated Sept. 24, 2019) (explaining that deadweight cost is “a cost 
to society created by market inefficiency, which occurs when supply and demand are out of 
equilibrium”). 
 2 See How Is Profit Maximized in a Monopolistic Market, INVESTOPEDIA, 
https://www.investopedia.com/ask/answers/041315/how-profit-maximized-monopolistic-
market.asp (last updated Apr. 2, 2019) (explaining how a monopolist controls the market 
through control of the price and quantity demanded). 
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is patented? How much does venue matter in patent litigation? So you litigators 
out there will appreciate that one, and it is a fraught issue. Does it matter where 
a lawsuit is filed, in terms of its outcome, when we are talking about patent 
litigation? And do patents contribute to rising drug costs and cause pharma 
companies to produce what we call “me-too drugs”?3 
In different papers, I have touched on each of these different questions. [But] 
obviously we have a limited amount of time here, so I am just going to talk about 
a couple of my research papers that I have been working on to give you a flavor 
of how data can play an important role in designing optimal patent policy. 
To begin, which industries care most about patent-term? This is a paper that 
is forthcoming in the American Law and Economics Review and as I said, our 
conventional wisdom is that patents matter the most in pharma and biotech. But 
is this necessarily true? How can we test this? In this paper, I take advantage of 
what we call in economics, a “natural experiment” approach.4 Most of you are 
probably familiar with the Agreement on Trade-Related Aspects of Intellectual 
Property Rights (“TRIPS”), right? And what did it do? It changed patent term 
rules in the United States. Before TRIPS, you had a fixed seventeen-year term 
as of the date of patent issuance; after TRIPS, you had a potential twenty-year 
term, marked from the date of patent filing. So, I am going to take advantage of 
this change in rules to try and get at in which industries patents actually matter 
the most. 
So, to lay this out for those of you who might not be familiar, patent 
prosecution is a back and forth process where you apply for a patent at the U.S. 
Patent and Trademark Office. Then the USPTO issues a response to you and as 
a patent applicant you file your response to them and then you go back and forth 
and eventually, the patent might issue. So, in this example, let us just say it took 
four years for the patent to issue. Under the old rules, how much patent term 
would you have? You would have a seventeen-year term from the date the patent 
issued. Under the new rules, what is your term going to be if you took four years 
to prosecute the patent? Well, now the twenty years is counted from the date you 
filed your application. So your effective patent duration is only sixteen years. 
Now, why does this matter? Under the new rules, you have an incentive to 
speed up your patent prosecution, and there are ways in which you can actually 
                                                          
 3 See Yaniv Heled et al., Why Healthcare Companies Should Be(come) Benefit 
Corporations, 60 B.C. L. REV. 74, 84 (2019) (describing “me-too drugs” as involving “an 
increasing number of pharmaceutical companies pursu[ing research and development] 
projects aimed at developing therapies for ‘lucrative’ medical conditions, many of which are 
not considered severe or which already have effective therapies available”). 
 4 Malcolm B. Coate & Jeffrey H. Fischer, Why Can’t We All Just Get Along? 
Structural Modelling and Natural Experiments in Merger Analysis, 8 EUR. COMPETITION J. 
41, 46 (2012) (comparing natural experiments in economics, where policies are observed 
over a period of time, to controlled experiments, where the conditions are set). 
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speed up your patent prosecution by being quicker in your responses to the 
Patent Office. And so, what might we predict? We might predict that in 
industries in which patent term is particularly important, you are going to speed 
up patent prosecution more than in industries in which patent term is less 
important. 
So, the question is, who sped up the most in response to TRIPS? First of all, 
the usual suspects, such as drugs, genetics, organic compounds, certainly did, 
but they were not the only ones. It turns out, that [other areas, including] 
communications, computer hardware and software, electronic business methods 
and software, and semi-conductor devices, all sped up [in patent prosecution] in 
response to TRIPS. 
So, what does this mean? It is not conclusive, but it is at least one data point 
that suggests areas that we think may not care so much about patent protection 
might be more sensitive than we think. Maybe patent duration matters more for 
software patents than we thought. Maybe, we used to think, well, software is 
going to be obsolete in seventeen to twenty years so we should not care. Maybe 
that is true, maybe it is not, but these areas did seem to respond to TRIPS in a 
way that was kind of surprising, whereas mechanical patentees did not respond 
much, so not everyone sped up. So, patent term might matter more to computer 
software patentees than we previously thought, and we are able to use data to try 
and look at that and challenge what the conventional wisdom actually might be. 
I should follow up, there is another paper that I am writing on this that takes 
advantage of the fact that this rule was retroactive, and we tie this to stock market 
events study data to look at the companies that benefited the most from the 
retroactive application of this rule. We look at what happens to their stock 
market prices and then we are able to use that to back out the dollar value of an 
additional year of patent protection. That is a work still in progress. 
The second paper I am going to talk about [involves] what we call a field 
experiment. So, there is this big, basic question: Do consumers actually care 
about patents? When you see a product and it says patented on it, and you are a 
consumer, are you more likely to buy the product than if it did not say anything 
at all? So when I ask this question to patent attorneys, I say, how many of you 
think [this fact] makes people more likely to buy the product? About half the 
people raise their hands, the other half do not. So, it is not clear. 
But are consumers more likely to buy a product when they find out it is 
patented? You might say, “Well, Neel, all you [have] to do is compare the sales 
of patented and comparable unpatented products and see which one sells more 
and you will have your answer.” Well, the problem is, you cannot really make 
apples-to-apples comparisons like that very often. A patented product is 
different from an unpatented one. So, I cannot just look at raw sales data to make 
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that kind of analysis. 
So, what do I do? I run an experiment. I go to a retail pharmacy chain that has 
agreed to let me do this, and I make more salient the patent status of all the 
patented goods there. So essentially you go in and you put a big “patented” label 
on the front of the product. Since I have multiple stores, what I do is in one store 
I use a patented label that says, “this product is patented.” In the other store, I do 
not put that patented label and so [I utilize] what we call in economics a 
difference in differences technique.5 I can compare how the sales change in the 
treated store versus the control store over time, and that gets me the estimate of 
what happens when we make patent status more salient. In other words, once I 
sort of hit the consumer on the head with the fact that this product is patented, 
how does it affect their purchasing behavior? We can actually get at a causal 
impact through this mechanism. 
Now, obviously, I cannot ask all the consumers in the store what they are 
thinking when they decide to purchase or not purchase a product. [The] only 
thing I can do is look at the retail scanner data after the fact. So how can we get 
at more detail with respect to what the consumers are actually thinking? Well, I 
also run this as an online, randomized experiment. [I show consumers pictures 
of products with] the only difference being whether a patented label is present 
or not. [Some] products actually say they are patented on the front, but [others] 
do not. When you do this treatment, people do notice it and they report that the 
product with the patented label is more innovative. 
So, when you compare the responses of the people who received the treated, 
patented label, versus the people who did not, the people who received the 
patented label do respond and say it is more innovative. They do say the product 
is better made. However, they are not more likely to buy [the product]. They will 
say, “Yeah, yeah, it is more innovative, it is better made, but I am actually not 
more likely to purchase it.” 
Now, you might think, this is an online experiment, so I am not actually asking 
them to spend their dollars, right? So, a person’s reported preference in the 
survey might be different than his or her actual purchasing; in economics we call 
this revealed preference. This is where the store experiment comes in. I could 
use the retail scanner data to look [at the following]: When I make the patent 
status more salient, what happens to sales? It turns out, at least so far, that the 
retail scanner data confirms the last result. In other words, once you make patent 
                                                          
 5 Difference-in-Difference Estimation, COLUM. U., https://www.mailman.columbia.edu/ 
research/population-health-methods/difference-difference-estimation (last visited May 29, 
2020) (explaining the difference-in-difference technique as “a quasi-experimental design … 
used to estimate the effect of a specific intervention or treatment … by comparing the 
changes in outcomes over time between a population that is enrolled in a program (the 
intervention group) and a population that is not (the control group)”). 
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status more salient, people are not more likely to purchase the product. That 
might not be true for all products (maybe you need larger sample sizes) but at 
least this starts the conversation as to what consumers actually care about. 
I should also mention, I did some background research on what people 
actually know about the patent system as part of the online survey, and I was 
actually heartened to see that people knew more than I thought. For example, in 
my survey of about 2,800 folks, about 83 percent knew [about how one obtains 
a patent; they knew that one obtains a patent] by getting approval from a 
government agency. In addition, 31 percent recognized [a patent] as a 
government-granted monopoly, and 21 percent recognized it as, “Okay, a 
product is using a new technology.” When ask[ed], what must one show to get 
a patent, the most common answer was [that] the product is different from 
existing products. [While] this is not a perfect answer, it is surprisingly good. 
So, people do seem to understand what patents are, which is another result. In 
conclusion, people believe patented products are more innovative, but that does 
not necessarily make them more likely to buy a patented product. 
I can now briefly talk about a couple of other research projects, [including 
one that asks,] how much does patent venue matter to litigants? You litigators 
out there will remember that there is a case called TC Heartland that came out 
in 2017 that changed patent venue rules.6 Essentially, it greatly restricted where 
patentees can file patent infringement suits.7 They used to file them all in the 
Eastern District of Texas, and now, a lot of these cases are shifting to the District 
of Delaware, where a lot of companies are incorporated. So, what we do is we 
run a stock market events study, which means you look at the stock market price 
of companies before and after the TC Heartland decision and see how the market 
responded to the decision as a way of kind of measuring how investors feel about 
it. Who is optimistic about this decision? If your stock market price goes up, it 
suggests you are really optimistic about this decision. So, whose stock went up? 
If you are a Delaware-based company who previously was really likely to be 
sued by non-practicing patent entities, some folks refer to them as patent-trolls, 
you were optimistic; your stock market price went up a lot. So, this is a paper 
that, with Ofer Eldar over at Duke, we published in the Cornell Law Review. 
Another paper asks, how can we reform patent law to encourage meaningful 
pharmaceutical innovation and lower health care costs? I do not have time to get 
into the details of this because obviously it is a complicated area, but one of our 
ideas is to try and encourage something we call value-based patenting. In the 
healthcare sphere, there is this whole thing about value-based pricing. We talk 
about this notion of value-based patenting. So, the idea here is, maybe we should 
                                                          
 6 TC Heartland L.L.C. v. Kraft Foods Grp. Brands L.L.C., 137 S. Ct. 1514 (2017). 
 7 Id. at 1519–20. 
2020] The State of Innovation in the Union 11 
have patent protection that is variable, that is dependent on the emerging value 
of the technology in the medical and drug device area. And so, we can actually 
go much farther than we could in the past because electronic medical records 
allow us to more accurately measure the value of new technologies as they 
emerge. [T]his is a paper in the Minnesota Law Review with my colleague Gregg 
Bloche. 
So, the bottom line is, data is something that not only can help us answer 
existing policy questions, but [it can] tell us what questions we should ask in the 
first place. Every time you answer and say, “Consumers seem to care about 
patents, [or] consumers do not seem to care about patents [when it comes to] 
their purchasing behavior but they say it is more innovative,” that produces 
another question [of] “well why is that the case?” [So data] sets the stage for 
thinking about other questions we may not have even thought of looking at 
before. It provides a neutral way to test whether the conventional wisdom is 
correct, which relates to the TRIPS paper that I talked to you about [in which] 
we just assumed patents are important in some sectors and not others. This is a 
way of actually testing to see whether that is true. And the exciting thing is this 
is an unprecedented opportunity that we have today, to use data in patent policy. 
We have higher quality data than ever before, and we [also] have better empirical 
techniques and computational analysis than ever before. So, I hope that my 
research and the research of others in this field really pushes things forward and 
increases the use of data in patent policy. Thank you. 
[Applause.] 
EVERARDO RUIZ: [So far] we [have] talked about kind of the description 
of what is happening, you know, where the research is; then there is what is the 
government doing? There is obviously a lot of pro-innovation [type] policy. In 
the second portion here, boots on the ground, the U.S. government promoting 
innovation, I wanted to bring up Paul Zielinski, Director of the Technology 
Partnerships Office at NIST. [When] we think of NIST, we maybe think of 
something else, but [NIST is] involved with voting standards and technologies 
surrounding democracy [and] cybersecurity. [NIST can answer questions like,] 
what is being funded? What is working? So, let us go ahead and listen to that. 
Paul? 
PAUL R. ZIELINSKI: Thank you. I really appreciate the opportunity to come 
and speak with you today. This is something that is very near and dear to my 
heart. I actually have the privilege and honor of doing two different kinds of 
things in my position over at NIST. Not only do we do a lot of research as a 
federal laboratory in various areas of standards and [into] some really high tech, 
interesting things, [but, in my role,] I [also] get to transfer those things out of the 
laboratory and to the marketplace directly. 
The other thing we [do comes as a result of being] part of the U.S. Department 
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of Commerce. As part of the Department of Commerce, we actually have a lead 
role in coordinating this activity across all federal agencies, for the government. 
So, I want to talk mostly about that topic today and I think it is really relevant to 
this group, especially since we spend a lot of money on federal research 
throughout the United States every year. [It is] roughly in the neighborhood of 
about $150 billion a year, so that is a lot of money that we are putting out there. 
But I always make the point, and I know this group is not really surprised by it, 
that we do not make anything. We do not manufacture, we do not distribute, you 
cannot buy consumer goods from the government; it is just not our role. So, 
intellectual property really serves as that key bridge that allows us to get things 
out of our laboratories and into the marketplace. If you look at the Department 
of Defense, they are not out there manufacturing these things, they are buying 
them. All this technology needs to find its way into the marketplace and that 
requires a lot of money. So, I talk about $150 billion, but there is a lot more 
money on the private side. That is really where the intellectual property rights 
come in as a way to protect that investment and those dollars that are going to 
be put in from the private side and are going to support the development and the 
transfer of that technology to the marketplace. 
So, this is a really high priority for the administration. President Trump even 
put in his President’s Management Agenda what we call a cross-agency priority 
goal. [Therefore,] this is one of the highest priorities of his administration in 
terms of how we are going to manage things. So we have a part called lab to 
market, we have multiple agencies involved in this whole thing, we have a 
number of different workgroups over at the National Science and Technology 
Council (“NSTC”), [and] we have a group that supports that. Again, the whole 
concept is getting inventions and ideas out into the marketplace and getting the 
funding for those on the private side [in order] to create new products and 
services. So not a great big surprise. Well, one of the interesting things about 
this cross-agency priority goal is this is one of those few things that actually 
crossed over administrations. And so, although it is in President Trump’s 
Management Agenda, you would also find this in President Obama’s 
Management Agenda, which I think is one of those rare things that is really 
heartening to see. [It is heartening] that this is such a priority for the federal 
government. Again, it is because we spend so much money on doing research 
and how do you benefit the people in the United States from that research 
investment. 
So, let us talk a little bit about how we are doing in these types of things. We 
just talked a bit about data, so let me share with you a little bit of 
data. Unfortunately, the best data we have is actually from 2016. In fact, my 
office actually produces the primary data sets on federal inventions that you get 
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out there. [There are] a couple of big points that you can see looking at the trends 
overall once you normalize everything. [For example,] we do great in doing 
partnerships; our cooperative research and development agreements are 
CRADAs. So, we work with other parties, and one of the most important parts 
of these agreements is actually the transfer of intellectual property rights. Some 
of the other primary things that you get out of these [agreements] are the abilities 
to work together, to create knowledge, and to create ideas and put them out there 
in the marketplace. So, you get an advantage out of working with the folks that 
we have in our laboratories. 
The disappointing part [of all this] is that our invention disclosure is a bit 
down. Fortunately, licensing activity is up, but again, sort of the bottom line to 
all of this is that we are pretty much flat on funding. So, it is not a great big 
surprise, but if you are not funding new things, you are probably not seeing much 
return on that. But we are doing a better job at licensing those inventions out, 
and again, that is the most critical thing that we can do because nobody is getting 
the benefit of these inventions if they just sit there. So, just looking intramural, 
the $150 billion [I mentioned before] is what we spend on all research and 
development. We will get [the money] roughly in thirds: about a third goes to 
universities, about a third goes to industry, and about a third of that is within our 
federal laboratories themselves. So, [we are] looking at roughly a third, only a 
mere fifty billion [dollars] or so. 
So, where are we doing patents? Where are we seeing actual inventions 
coming out from our laboratories? Of course, you get the big other category, but 
it is pretty well distributed; we do a lot of different work. [When it comes to] 
sensors and measurement, of course, I am happy to see from NIST that 
measurement is such an important thing. [But] how we are doing sensors, 
[including] how we are actually picking up these things in the environment and 
how we are understanding our systems, that is incredibly important. Really, there 
is a pretty wide distribution of where these patents are coming from in terms of 
industrial sectors. To put a number to it, we pursue roughly 2,500 patents a year 
in our federal laboratories, which is not a huge number, per se, versus a lot of 
industries. The flip side of that is we only patent things where we really need to 
use [a patent] to raise capital, and we transfer it to the private sector for them to 
raise money. So that is where we are with what we are investing in. It is also a 
pretty good snapshot of how you would work with a federal laboratory and 
where you might find some of this information. 
Now, we have many databases out there with different pieces of 
information. For example, if you want to find information about what we are 
doing under the President’s Management Agenda, you can go to a website called 
performance.gov. Specific information on patents that are available across 
agencies comes from our Federal Laboratory Consortium, and we actually have 
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another lovely website, federallabs.org, and you can find information there. 
So, one of the things that we have done recently at NIST is put together what 
we call our green paper. What is a green paper? It is really just some ideas; it is 
a discussion paper. What we did is we went out last May and we asked: What 
can we do better in terms of supporting innovation within our federal programs? 
This includes the entire $150 billion; how do we better transfer this to the private 
sector? How do we increase what we call return on investment? This does not 
necessarily mean dollars to the government, that is not the return we are looking 
at here. But, how do we get a better return in terms of jobs, increases in economic 
performance, all of these lovely other things, for taxpayer investment in research 
and development? That is the return that we are talking about here. And so, what 
we did is we went out, we did our request for information, and we got many, 
many responses; [the number of responses] was really quite voluminous. But we 
came up with this paper and we have roughly fifteen findings in different areas 
and the idea behind it is how do we increase innovation? So, I welcome you to 
look at this at nist.gov/tpo/roi. We really do not propose any changes to the 
bedrock Bayh-Dole Act through this, but there are regulatory changes that are 
envisioned here. Some of the questions that we discuss in this green paper 
include: How do you fund university research? Also, when you get to the end of 
the program, and you say, “Well, I have this great idea, but I do not have enough 
money to get a patent on this,” how do you address that? We also talk about 
topics like software, how do we work with copyright versus patent, and how do 
you really do intellectual property protection? So, there are a number of great 
ideas in this [green paper] that we are trying to develop. And of course, the 
reason we call it a green paper is because it is simply a discussion piece that is 
meant to get people talking; it is meant to move things along. It is really not the 
document that makes the changes themselves. All of that will be coming and we 
do intend to move on this within the coming year. Now I will go all the way back 
to what I was talking about on the President’s Management Agenda. That is 
really where we are executing these [ideas and changes] at this point. They all 
fit into the milestones and the agenda that we are working on across the 
government. With that, I will conclude and turn it back over. 
[Applause.] 
EVERARDO RUIZ: So that was one perspective. But it is interesting; it is 
funny. I can think of the Rockefeller [era] back when a billion [dollars] was a 
billion [dollars], you know, we are talking about huge sums of money. But using 
it efficiently is obviously what everybody wants. So, thank you [Paul]. 
It is with pleasure that I now invite G. Nagesh Rao from the SBA up to the 
platform. If you recognize the name, you may have read it in Financial Times or 
TechCrunch. He has been around on a lot of different platforms, but he has also 
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been involved with growth accelerators and Patents for Humanity, [working 
with] a really wide, diverse set of uses for intellectual property. So, I thought it 
would be perfect for him to come here and talk about innovation kind of as he 
sees it from the SBA. 
G. NAGESH RAO: Thank you [Everardo] and thank you everyone. Again, it 
is nice to be in the same room with my friend Jeff Langer. I have known him for 
about fifteen to twenty years now, both of us are alumni of Rensselaer 
Polytechnic Institute (“RPI”). So, thank you all for having me here today. I also 
see some former colleagues of mine, [including] Paul [who has been] wonderful 
as always. He and I used to work on the Technology Transfer Lab-to-Market 
efforts [together]. So, I am looking at this from a couple of different lenses. I 
used to work on the Small Business Innovation Research (“SBIR”) program,8 
but I do not work on that anymore. I now engage in information technology 
(“IT”) modernization efforts for the agency because of the great job I did on 
sbir.gov. I asked Paul to help me out here with this because I think what is really 
important is understanding the different resources that are out there when it 
comes to innovation, intellectual property, and scaling up for startups and small 
business companies. You know it is funny, we have already talked about patents 
and that is the elephant in the room, but it is not just patents, it is trademarks and 
it is copyrights; it is the notion that intellectual property is an asset. The property 
right is an asset, an asset that you can leverage. 
So, I worked for seven years at the Patent Office, then I went to the private 
sector for a while, and then the SBA reached out to me and said, “Hey, come on 
back and help us out with venture capital private equity” because I was doing a 
decent job out in the private sector. I was actually doing patent curation at that 
time out in Silicon Valley for a number of high-tech startups, some of which you 
may have heard of. What was really fascinating was talking to the people there. 
They would ask, “Why do I care about patents?” But, half the time, they were 
conflating the terms patents, trademarks, copyrights, and they did not even 
understand the value proposition. 
When you look at the valuation of any startup or small business, the 
accounting equation is that assets must always equal the liabilities plus 
shareholder equity. That is a standard accounting equation. So, when you look 
at that value proposition, you need to understand that intellectual property is a 
valuable asset. It is an asset class that rises in value over time. And I think what 
has been critical here is that when we look at high tech research and development 
(“R&D”) perspectives, that asset of intellectual property actually has a really 
                                                          
 8 About SBIR, SBIR, https://www.sbir.gov/about/about-sbir (last visited May 29, 2020) 
(explaining that the SBIR program is the Small Business Innovation Research program that 
helps small businesses to “explore their technological potential and provides the incentive to 
profit from its commercialization”). 
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strong return on investment down the road. I mean, the investments that we have 
made since the 1970s have really materialized to this day when it comes to R&D. 
That is why what the question comes down to is how much of that furthering of 
R&D, those investments, [can be attributed to] the private sector? [Is it 
attributable to] the private sector plus the public sector? What does this really 
look like? I know when I worked on the SBIR program, there were some 
economic studies done. In terms of data, the National Aeronautics and Space 
Administration (“NASA”) SBIR program produced a four to one dollar return 
on investment for every dollar that NASA SBIR contributed. For the Air Force, 
it was a fourteen to one dollar return on investment. For the Navy, it was a 
nineteen to one dollar return on investment. 
Half the technologies we see in our lives today had some sort of 
federal R&D funding to it, whether it was SBIR or something affiliated with it. 
In fact, 80 percent of the components of [the cell phone], this device that we are 
addicted to, were [the result of] R&D funding from the federal government SBIR 
program. Actually, 100 percent [of these components] are [a result of] R&D 
funding from the federal government when you think about it. Ultra-Scan 
Corporation came up with the biometric touch, Photobit did the CMOS pixel, 
which was Eric Fossum’s work, and Qualcomm did the microprocessor. So, 
there is an important role that the government plays in de-risking technology 
development and spurring innovation forward. I know you all know that, but I 
think it is a fascinating thing when you look at it from the SBIR lens. Still, I 
think it goes beyond that, and Paul, if you do not mind, please step up for a 
second and talk with me about this. [Describe what it is like] when you look at 
it from phase zero to phase three and examine all those different bridges that are 
helping with the commercialization valley of death. 
PAUL R. ZIELINSKI: One of the things I get to do for NIST is probably run 
the smallest SBIR program in existence. It is pretty exciting to do because we 
do basic research in a lot of our laboratories. If you look at universities, they do 
a lot of basic research. The question really becomes where do you get the money 
to cross this valley of death? The research institutions typically are not able to 
bring things to the level of maturity and de-risking that a company needs in order 
to get into the marketplace. I just went through the whole thing about, “well, we 
rely on private capital,” of course, that is the reason why we have intellectual 
property; when we want some investment, we need to get money from the 
private side [since] we cannot fund everything from the government side with 
what we have available. However, we can actually try to spur innovation with 
something like an SBIR program and that is really the key. In fact, I know [the 
program’s] tagline is “America’s Seed Fund.” So, the idea is, this is our 
investment in small business and how we try to use that SBIR program to 
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basically kickstart some of these small businesses so they can grow up and 
become bigger businesses and, oftentimes, have an exit event. But that is great 
because that puts products into the hands of people, and that is really the goal of 
all of this; [the goal] is not just to develop things, it is to make a difference in 
people’s lives. 
G. NAGESH RAO: Agreed, and I think what is critical is that when you look 
at innovation in America there is this à la carte approach. Large companies play 
their role and small companies also play their role. I mean, Steve Sasson, who is 
a good friend of mine, he would say, back when he invented the digital camera 
for Kodak in the 1970s, “If I had known the SBIR [program] was around, I may 
have thought about that. I might have said, all right, I will leave Kodak and I 
will go start my own small business company.” Now what is interesting is the 
fact that there is an opportunity like this, especially since many countries do not 
have this opportunity. [Here,] we are reinvesting in our society; we are 
reinvesting in our talent pool. You know, intellectual property is the result of a 
heterogeneous society. It is the result of a diverse society, a very culturally mixed 
one. I think that is what is so interesting about Silicon Valley. [Out there] I see 
this cadre of intellectual minds from a multidisciplinary perspective. That is 
what moves the engine; that is the fuel that drives the economic engine forward. 
So, what you look at is what are the catalyst points? What are the little nuggets 
that come in, molecularize around, and then go up? I think you are looking at 
these different catalysts and federal funding, R&D funding, is the government’s 
way of outsourcing R&D needs. Really all we are doing is catalyzing that 
movement and really the private sector moves it forward down the road for that 
mass scale, long-term commercialization, but you need to have someone to make 
that first bet. And it is a non-dilutive and you get to keep the intellectual 
property; that is a steal at $2.5 billion per year. That is my quick observation to 
you all. The last thing I was going to say, [focuses on how] different technology 
is progressing. So, it took sixty-eight years for the airline industry to hit fifty 
million users and Pokémon GO just a couple of weeks; that is crazy. But that is 
also the sign of disruptive innovation and I think that is a dialogue we need to 
be having with ourselves; as you allow for this faster timeline to happen with 
disruptive innovation, how do we come to equilibrium with it? 
[Applause.] 
EVERARDO RUIZ: A good observation. Those are like shock waves at the 
end. They are not slow and steady waves. So, those were a couple of perspectives 
and we are talking about huge figures of fifty billion, or even a couple of billion 
[dollars]. Interestingly enough, you can say it is a Silicon Valley thing, but it is 
not like innovation does not happen worldwide, and it transitions everywhere in 
the world. I keep thinking about moving around Saudi Arabia and seeing people 
with iPhones with fifty thousand patents tied up in this phone when it comes to 
18 THE CATHOLIC UNIVERSITY [Vol. 28.2 
 JOURNAL OF LAW AND TECHNOLOGY 
digital rights management (“DRM”), memory control, software, and the 
processor. And yet, there it is, and it is more than we went to the moon on. It is 
incredible and worth protecting. 
Next, let us pivot to [the concept of being] in the trenches. I alluded to asking 
people that are fighting the fight in the trenches, what is happening, what is 
working, what is not. So, let us pivot over to that view from the trenches. PJ 
Bellomo, Executive Chairman of Blue Sources, will start the discussion. Also, 
one thing I have noticed with all of these [presentations], is that it is no longer 
just one technology, it is all very interdisciplinary. So, we look forward to 
hearing [PJ’s] discussion. 
PJ BELLOMO: I am PJ Bellomo, Executive Chairman of Blue Sources. Our 
patented water security technology detects toxic chemicals in water by 
combining artificial intelligence with a 24/7 real-time data feed from the world’s 
most advanced water quality sensors: live fish. So, here is the story. A few years 
ago, United States public water utility, Tuesday afternoon, all quiet on the 
western front, pH is fine, dissolved oxygen is fine, conductivity and all the other 
typical physical water measurements [are fine]. What you want in a water utility 
is you want the operators absolutely bored out of their minds because everything 
is working fine. First-generation Blue Sources device alarms, the fish, say, 
“Something is wrong with the water.” Therefore, something must be wrong with 
the Blue Sources device because everything else is fine. So, we go through a 
routine where we switch out the fish; it is a normal routine that happens every 
couple of weeks. We put in new fish, and they alarm as well. Well that is a little 
unusual, [since we used] two different sets of fish. The operators then take a 
water sample and it comes back from the lab. [They say,] we have a problem, 
this water is filled with diesel fuel. We do some investigation, and, keeping some 
things confidential, I will just say there is a barge out on the source waters with 
a massive problem: a leak from the diesel fuel tank is going into the water, and 
that water is going into the intake at this public water utility. Fish saved the day 
because none of that [water] went to the public. 
Now let me tell you a little bit about a technology transfer story. The United 
States Army is worried about a problem. It is worried about accidents and 
negligence, but it is more worried about sabotage. So, problem number one that 
the Army is worried about is it is going to have troops deployed somewhere, 
maybe even at a base in the United States, and instead of some of the enemy 
putting explosives inside of a vehicle and trying to go through the front gate and 
do nefarious things, [the Army is worried that] the enemy might just poison the 
water supply. This is a problem that Blue Sources is working on [solving]. 
There is also a different problem, and this [problem] is not as obvious. While 
there are many places in Southeast Asia where they have water problems, there 
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is a place in particular where they had water problems and they spent the last 
fifteen to twenty years fixing those water problems. Therefore, today the answer 
for [accessing] drinking water [in this area] should be to open up your tap 
because on average you are going to have better water than if you got your water 
out of a city in the United States, which actually has very good drinking water. 
But that is not the answer, and [the people there] still use bottled water, which 
makes them spend a lot of money they do not need to spend. This then also 
creates a recycling issue with all the plastic. So those are problems that we can 
solve. To help do so, we have this patented device we can use. We actually 
access this [and similar] patents through a tech transfer program through the 
United States Army, and we have a cooperative research and development 
agreement [in place]. 
As far as how it all works, the secret is twofold. [First there are] the patents 
around the entire system. To take away the mystery, I will tell you that, and as 
it turns out researchers have known this for a while, when a fish is breathing, it 
gives off a localized electric field. Moreover, Mother Nature has been working 
on these fish for ten million years, so if you put bad things in their water, they 
breathe differently, and when they breathe differently, those electric fields 
change. In our device, we have eight fish and we are monitoring those electric 
fields, and [the fish] essentially vote with their breathing. We then send those 
signals, as well as physical signals about the water, into a neural network and 
the neural network determines whether or not there is a problem. So, that is what 
is going on. We are actually in the valley of death that [was just referenced]; we 
are actually trying to make our way through the valley of death. We have a 
market ready product, and we are trying to win some customers before we go 
out for funding and target markets, government facilities, drinking water, and 
then wastewater. [In fact,] the first-generation device is actually serving all of 
these markets. 
Now I am moving really quickly but what I will tell you is I have been asked 
to talk about this state of innovation. Well, I am just a guy who is out there 
running startups, so I have a limited perspective and it stems from my personal 
experience. So, I thought I would explain my resume so that when you 
understand my perspective, there are these inherent limitations. I had a 
traditional career, and I was another RPI geek by the way. I worked as an 
engineer for many years, and then I was sort of a corporate suit doing consulting 
for Fortune 500 companies. Then, one of my clients hired me and I did e-
commerce and supply chain work. Finally, in 2002, I found my home in the 
startup world. So, I will discuss the state of innovation but let me [first] take 
these last seventeen years and comment a bit. I have been an executive for six 
startups, I am currently the executive chair at Blue Sources, I have been the chief 
executive officer for [several] software startups, and I have also been the chief 
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operating officer at a startup. When you are at a startup, you look for exits, and 
I have only had one [exit], since [one of the startups] had the good fortune of 
being acquired for $45 million by a public company. I have also invested [in 
startups] myself; I have taken my hard-earned money and I have invested in four 
startups. 
There was also a period in that seventeen years during which I worked with 
the partner of a software design firm. So, I did the design work on two other 
pieces of startup software. I have also personally been in two different pitch 
competitions. Since 2010 I have been a member of Mindshare. I think about 
twenty years ago, the guys from AOL started this not-for-profit called Mindshare 
to help the next generation of entrepreneurs prepare to run companies, and at 
this point, I think Mindshare has brought 850 CEOs such as myself through the 
Mindshare program. And so, I am part of this 800-person CEO network. I have 
served on the board of directors at a startup accelerator. I have served on the 
board of advisors at techfrederick. I recently had the good fortune to be able to 
mentor at the New York Business Plan Competition a group of college students 
pitching startup ideas. I have been an occasional entrepreneurial guest lecturer 
and I was a finalist for a professorship, an endowed chair professorship in 
entrepreneurialism. I did not get that, but [this shows] that I also have an interest 
in the academic area. So, it is with all of that that I offer my perspective on the 
state of innovation. 
Quite simply, my experience has [shown me] that intellectual property law 
has worked; it has worked in the world that I have lived in. However, there was 
one problem that I encountered while running a company and it had to do with 
what I refer to as a patent troll. But the Supreme Court handled that [issue] in a 
case that happened about five years ago. That case actually made the patent troll 
disappear.9 [On another note,] one thing that does not get discussed is the call to 
refrain from changing bankruptcy law. There are places that cannot take the risks 
that we can take. I have never had to take a company through bankruptcy, but 
anybody who has invested widely in startups probably has done that. 
[Bankruptcy] does not come back on the individuals and that is the bedrock that 
allows the culture here to continue to work, and I think that works really well. 
Somehow, in the United States, at least in the world I live in, if you try hard and 
you fail, it is okay, and that cultural view is really important. I do not brag about 
my failures, I do not wear my failures, but I have certainly had some, and I think 
this [acceptance approach] works really well. So, those are all real pluses to the 
state of innovation, and while there are still some things that we can improve on, 
my read is that [the state of innovation] is alive, well, and thriving. Frankly, I 
                                                          
 9 Octane Fitness, L.L.C. v. ICON Health & Fitness, Inc., 572 U.S. 545 (2014). 
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wish I was pursuing my engineering degree now because I am finally at home 
in the startup world, and back then it did not seem as accessible. 
So, where do I think we can improve? Intellectual property protection costs 
are still very expensive. At Blue Sources, I have taken over a family of patents, 
and [these patents] have helped us get where we are today. But, just the 
maintenance costs on those patents [are substantial.] Now, I do not know how 
to fix that issue, and lawyers need to get paid, but maybe a startup will figure 
out how to lower [intellectual property protection costs]. That is one area I think 
we can improve in. For my last two problems, I do not know how to fix them, 
but I am not bashful about drawing attention to them. With the growth of 
entrepreneurialism around the United States, there are all these posers that are 
surfacing. I will not call out the specific schools, but I had the good fortune to 
be a finalist for an endowed chair [professorship] and there are all of these 
professor of entrepreneurship [positions] around the United States; it is like this 
new thing. And let me tell you, not only am I not qualified to apply, but, if Steve 
Jobs was still around, he would not be qualified. Elon Musk, Bill Gates, they are 
not qualified. They do not satisfy the job requirements for most professor of 
entrepreneurship [positions]. You need a PhD, you need years of teaching 
experience, and you need to be widely published to be able to teach students to 
be entrepreneurs. 
[Applause.] 
PJ BELLOMO: I mean, it is absolutely ridiculous; I do not know what else to 
say. The last thing I will say has to do with a very delicate topic. I believe the 
way we handle healthcare costs, but more specifically health insurance, is 
actually something that gets in the way of innovation in the United States. Now 
that sounds like a leap, [and you may be asking,] “What is the connection?” 
Well, I will tell you. I do not know about anyone at Kodak, but I have friends 
that were at Qualcomm, IBM, Apple, and Microsoft who have done well. [They 
are] engineers, maybe managers now, and product design people, [and they 
worked in these roles for] fifteen to twenty years. My 401(k), it is in good shape; 
I have made good money and I am ready to take a chance. But you know what? 
I have a four-year-old with juvenile diabetes and I just cannot [take that chance]. 
I am standing in front of you today as a man whose grandmother and grandfather 
died of cancer, father died of cancer, mother survived cancer, older sister 
survived cancer, cousin died of cancer, and who survived cancer. Making the 
decision to go into a startup world that might lead to failure and could leave me 
without a job in six months and with no healthcare insurance is absolutely 
terrifying. There are geniuses all around America ready to come out and help the 
innovative world, and they are stuck in jobs because they cannot take the risk of 
going out and someday finding themselves without health insurance. I have no 
idea how to solve that problem, but I have never heard anybody speak about it. 
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So, given that I had a microphone for ten minutes, I thought I would raise [the 
issue]. Now, let me end the way my partners always like me to end: You want 
safe, clean water? Trust the fish. 
[Applause.] 
EVERARDO RUIZ: Passion. I like it. Again, interdisciplinary. I mean at first 
I thought, “Fish? What?” That is because I am coming from the semi-conductor 
world and disciplines like telecommunications and electronics measurement. I 
thought, “You have to be kidding me.” But then I realized that [PJ offered] a 
good approach. Interesting. 
By the way, as a side note, I remember looking at a deal in Poland, and that 
the laboratory that first figured out how to make silicon wafers had to pass. Why? 
Well, what does the bankruptcy law look like? They had not even tried [using] 
it. It had not been exercised. So, I am sort of in violent agreement with the point 
there. 
We are now going to move to pumps. From Zoeller Pump, we are going to 
have Matthew Byers come up, who is the corporate intellectual property 
manager [at the company]. You know, there is a tendency when you think of 
pumps to think of water and oil and think it is this crusty, old business. But, 
despite [pumps] being mechanical, there are all kinds of electronics, software, 
and DSP involved, especially in a market that is a global market, and that is what 
we are going to hear about. So, take it away, Matthew. 
MATTHEW BYERS: I met Jeffery Langer last summer at the USPTO 
Intellectual Property Chinese Roadshow where I was giving a talk, and we 
became friends. Then, during the past year, he asked me if I would continue that 
presentation here with you all. 
So, I am going to talk about pumps. You may have heard of our company. 
Many people have basements and many people have sump pumps. We have 
succeeded over the course of eighty years in producing what we think—and I 
think that there is plenty of evidence to support this—is the best sump pump in 
America. We can claim that because we are also the most copied sump pump in 
America. Our design for our core product is actually utilized by many 
competitive products. 
Our main location is in Louisville, Kentucky. We have been doing this for 
eighty years and we consider ourselves a legacy brand. We also own a company 
in northern Indiana called Flint & Walling. Back in the day, they built windmills. 
So, when you look on the prairie and see those windmills, they were [made by] 
Flint & Walling. That company has been in business for 150 years. So, I figure 
they are like a legacy times two. We have about 950 employees and we do about 
$200 million per year in sales. We have an international presence. We are family 
and employee owned. We are community conscious and innovation minded. 
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So, we are talking about how pumps can be sexy and whatever. Well, we 
pump water. We pump sewage. We grind sewage up. We move it around. Pumps 
can be fractional horsepower, or they can be very big. They can be one hundred 
horsepower or larger. It is the engineering community that figures out what is 
needed. And then we build these things that are needed to move the water. They 
involve controls. They involve collection systems. There are environmental 
concerns. 
Anyway, so you have Zoeller Pump and Flint & Walling linking industries. 
We have our own plastic injection molding company. Years ago, most of those 
went away. We have one in Indiana and it is a very interesting process. We own 
large submersible pumps. Wolf Pump is down in Texas, and so are these large 
submersible irrigation pumps. We have a Controls Division up in Canada. We 
have a pump company in Taiwan. We have an environmental business in China 
which is now serving as a place for us to distribute our pump products, and I 
spend a lot of time working on the China project. I made about forty-nine trips 
in and out of China, since this [business] is brick and mortar. 
At Zoeller, innovation involves basically four areas. We have products, new 
products, product improvements, and manufacturing process. We build things 
and we do not want to share our processes, some of which are very old, but some 
of which are very new, with the outside world. So, we think about that, [when it 
comes to] sales and marketing processes and then business processes. I am now 
going to hit a few highlights of each of these. 
So, on the new product side, we had a conversation last night. We were talking 
about idea capture and what people do. What we do, [is] we keep people out of 
our R&D areas. If you come to our company, you cannot tour there, and that is 
just the way it is. I work with our engineers. I work with the people that are our 
technicians, the people that are working on technical things all day, every day. 
In our business, that is where innovation comes from, those people. One day, I 
am out in the field and I get invited to go to a distributor’s place. By the way, I 
am a technical guy; my area is decentralized wastewater. So, I can treat 
wastewater without giant sewer systems. Anyway, I go to this conference and it 
is a bunch of plumbers. They are in this distribution house up in Wisconsin. It is 
fantastic. It is wintertime. It is cheese curds. It is beer. It is local people sharing 
from their hearts exactly what their troubles are in their profession. It was 
wonderful. It was a great harvest. I bring that information back to the company 
[and] that shapes our next generation of basin systems. 
For example, you go out in the world, and you deal with actual practitioners. 
They will share with you and they will teach you things if you are smart enough 
to listen. Anyway, our people at our place, I encourage them to record their 
thoughts in “idea books.” I have gone around to all our divisions. I have 
distributed these books. They do not instantly write their ideas down. This is 
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something you have to say over and over and over. One of the things we teach 
these days is that communication does not really happen until the other side gets 
it. Well, do not expect them to get it the first time. So, you hammer away. 
We had a board of directors meeting the other day and our manager from the 
Taiwan facility came over, and he was thrilled to share with me their first idea. 
Now, they have had a bunch of ideas, but this is the one that is recorded in the 
“idea book.” It is really good. It is innovative. It is something that we will file a 
provisional patent application for in the United States, probably in the next ten 
days. It is a really great idea and it came from a bunch of young guys that were 
working together. It is a multi-disciplinary effort, but it is really, really 
something. 
Anyway, it was great to see that. Many ideas instantly going into “idea books” 
might be ideas that people are routinely working on. But maybe after a little 
while, maybe annually, or every six months even, you have a group of skilled 
people come and look at the “idea book,” people that are really good in your 
business, and they can separate the wheat from the chaff. They then select the 
ideas that we want to move forward. Certain ideas are going to be very exciting 
to us because we can make money. We want to make money. We want to earn a 
profit. All those 950 people that work with us, they have families, and everybody 
needs to get paid. And so, we get excited when we see something that we think 
we can commercialize. We want to avoid that area where we have this great idea, 
but we cannot do anything with it. 
So, we have “idea books,” we patent things, and we are teaching the folks in 
our business about diligence and what you have to do when you have an idea. 
Many people that have ideas, their ideas are born in a vacuum. They do not 
actually understand that there is another person on the planet that likely has the 
same idea, and then if they run into that, they get discouraged. Well, do not get 
discouraged. Move up one notch. You can do that. That is what we do with our 
people. If they have a good idea and they hit a roadblock, we tell them let us just 
take it to the next level. We ask, “what would be the next cool thing?” We 
encourage them to not let things die. Anyway, diligence is very important, and 
not just in the patent area. But if we build any product for sale, we have to do 
the diligence so we know we can sell it. 
Working with outsiders on products, that is huge. Work with consultants. But 
to hire a consultant you need the proper paperwork. You need to make sure that 
people do not reveal what you are doing. And then if you pay somebody, some 
technical person to do work for you, you need to make sure, contractually, that 
the work is owned by you, because if you have not done that right, you are going 
to have a problem. Also, when you have people in your organization working on 
innovation and going above and beyond, you create a reward structure. So that 
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is a little bit about products. 
[I will now move on to] manufacturing processes. In our factory, we have 
proprietary information [and] we have trade secrets. I have gone around to our 
various divisions and tried to help the managers understand that which can be 
shared and that which should not be shared. We do tours. We have factory tours. 
That is a big deal to us. Historically, we would show everybody everything. 
These days, my message is do not do that. In fact, I go to the people that want to 
show people things and I ask them, “What do you really want to show?” If a 
product is made in the USA, that is something we are proud of. You want to 
show that? Show that. Every one of our pump products is tested repeatedly. You 
want to show that? Okay, show that. [People may say] “I want to show quality. 
I want to show that we have this super high-level of quality.” Well, do you 
necessarily need to take the tourists into the quality laboratory and show them 
the instrumentation? 
One day I took the tour and I am standing next to a man from Indonesia. He 
is a brilliant engineer and he is asking really great questions. Surprisingly, the 
employees are answering them. They answered everything that he asked, and I 
was shocked. If it was me, [I would not have allowed this to happen], and in fact, 
in our company these days I have been accused of being anti-tour. Well, I just 
wear that mantle now; I am anti-tour and I am the no-fun guy. I am the guy that 
demanded that we revise all our labeling for California’s Proposition 65. That 
was unpopular. But anyway, that is a different topic. 
[Laughter.] 
There is also manufacturing, and I did want to cite one example. We have a 
machine. We have a computer numerical control (“CNC”) machining center in 
Louisville.10 When you buy a machine, the people are going to tell you the 
maximum that machine can put out given the parts you want to build. Well, what 
if you bring one hundred years of experience and direct it at that machining 
center? And all of a sudden, you start figuring out how to gang tool this thing 
and do some amazing things. Then the next thing you know, that machine is 
producing 125 percent of what the manufacturers said it would. As far as I am 
concerned, that is innovative. That is the sort of thing I do not necessarily want 
to teach the world. I do not know that I do not want to teach the world that, but 
I also do not know that I do. We have that type of thing going on all the time. 
Now to marketing. I highlighted marketing videos. That was a big deal for us 
recently. Our marketing people want to show everybody everything. Our 
marketing people contract with outsiders to build, say, videos. If you do that, in 
                                                          
 10 What Is CNC Machining? An Overview of the CNC Machining Process, ASTRO 
MACHINE WORKS INC. (May 22, 2017), https://astromachineworks.com/what-is-cnc-
machining/ (defining CNC machining as a “manufacturing process in which pre-
programmed computer software dictates the movement of factory tools and machinery”). 
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the file folder for that project, you will have written on paper, evidence of 
licensing if there is music involved. Music is a big deal these days, and 
companies our size are just learning about all this, but proper licensing is huge. 
Copyrights. In our business, we copyright many works. If it is original to us, 
we are going to copyright it. If our marketing people create a clever advertising 
campaign, you will see some copyright language associated with that, but our 
work may still be infringed. If there is infringement, we may not act, but at least 
we have a legal leg to stand on. Within marketing, these people come up with 
very creative works all the time. So, it is important for us to teach these people 
how to protect those works as best they can. 
We also have a couple of trademarks. This is in the area of marketing as well. 
One of these trademarks has to do with the color of our Model 53 pump. The 
other has to do with the image of that pump. Remember I said that the pump has 
been copied? Well, the good news is that pump has been in the marketplace since 
about 1982 and it possesses something called “acquired distinctiveness.”11 So, 
we were able to convince the USPTO to issue these trademarks, and we have 
successfully used these trademarks against several knockoffs. It is really great 
to have that ability. 
Finally, there are business processes. In your business offices, you might have 
people using software. You might buy, if you are a manufacturer, enterprise 
resource planning software and work with people that are coming in, consulting, 
and providing you a code. But maybe that code is not exactly right for you, and 
you make a number of changes and adaptations. You need to think about that. 
Those adaptations could become desirable to the people that provided you that 
language. Also, all of that could be copyrighted, and you need to think about that 
on the front end. You also need to realize that if you are playing with these 
things, you may create something that is novel and that somebody else wants. 
This is an important consideration. 
At Zoeller, within the business office, you have different kinds of innovations 
happening such as with the IT code. In manufacturing, when it comes to our 
processes, we are not doing brain surgery, we are not out there on the cutting 
edge, but we have people working on very up-to-date manufacturing processes 
that are interesting to us and outsiders. We have products in development, 
products under improvement, and patents. We also filed various provisional 
[licenses] this year, and as those things become dated, we will follow-up. With 
                                                          
 11 Acquired Distinctiveness (Trademark) Law and Legal Definition, USLEGAL, 
https://definitions.uslegal.com/a/acquired-distinctiveness-trademark/ (last visited May 29, 
2020) (explaining that a mark acquires distinctiveness when, as a result of extensive 
advertising and widespread use, the mark becomes capable of serving as a trademark by 
associating the mind with a particular source of goods and services). 
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that, I will conclude my portion. 
[Applause.] 
EVERARDO RUIZ: Thank you. I have this specialized bicycle and on the 
seatpost it says, “Innovate or Die.” So, if you are competing successfully, the 
modesty was appreciated, but you are world-class. You have to be, or you are 
dead. Well done. 
So, we have talked about [the view] from the trenches. Who knew about fish? 
Who would have thought? We also talked about pumping. Again, everybody 
thinks it is some crusty, old industry. But we saw it is not at all. 
We recently had an internal discussion with the Patent Office about artificial 
intelligence (“AI”). We think about AI and how it is applied to a lot of things 
and not just used in isolation. It is employed in healthcare, astronomy, and a 
number of other fields. That is why our final speaker, Meghan, is here. She co-
founded and now leads the company VEDA Data Solutions. So, let us go ahead 
and invite Meghan here to speak. 
MEGHAN GAFFNEY BUCK: My name is Meghan Gaffney Buck. I am one 
of the two founders of VEDA Data Solutions. We are a data processing company 
in the healthcare space. We work primarily with Medicare and Medicaid plans. 
I wanted to talk a little bit about the state of innovation as it applies to AI, 
machine learning, and some of the newer technologies from both an intellectual 
property perspective and a general-competitiveness perspective. 
Just to kind of set the stage for healthcare, the reason why we are so excited 
about the opportunity to innovate in this space is because of the crushing cost 
that folks in these parts like to discuss ways to solve. One out of every three 
healthcare dollars is spent on administrative overhead. So, when we talk about 
healthcare dollars, we are talking about your premiums. One out of every three 
dollars does not leave enough money in the system to adequately care for 
patients in the way that we need them to be cared for from the beginning of life 
all the way through the end of life. In addition to that, health plans alone are 
spending $10 billion inefficiently due to data inaccuracy. Data inaccuracy 
includes everything from having to manually hand key-in information because 
it has come in through a fax or a PDF that cannot be properly ingested into a 
data system, to improperly entered claims. Then on top of that, there is the fraud, 
waste, and abuse that exists in the system that cannot really be attacked, because 
today, within our healthcare environment, whether it is Medicare or Medicaid or 
private payers, they cannot even tell you accurately where physicians work and 
see patients across the country. That is where VEDA starts to attack the problem. 
But we come at it from a unique perspective. 
So, I come from a political background. I spent a dozen years in Washington, 
D.C. working with appropriators in the House of Representatives and Senate on 
the political side of the aisle, and healthcare costs were something that were a 
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constant topic of conversation. I had the chance about three and a half years ago 
to work with my co-founder, Bob Lindner. He is an astrophysicist and he was 
out of postdoc at the University of Wisconsin. 
He built an AI system that is now used in forty research facilities across the 
world, including NASA, to process radio telescope data in an automated way. 
Now, what was unique here is that scientists that are coming out of the hard 
sciences, particularly in astrophysics, biology, and chemistry, are used to seeing 
data in the real world. What that means is that it is messy. It is full of holes. It is 
messed up by every iPhone and Hot Pocket being microwaved on planet earth, 
and you cannot get any more of it. That data looks a lot like the data that you see 
in the healthcare system, data coming in on electronic health records 
(“EHRs”).12 If there is something that is miscoded, you cannot go back and say, 
“Dr. Smith, three days ago, you saw this patient. Did you really mean to code it 
that way?” So, data cleansing and dealing with imperfect data sets is something 
that is intrinsically valuable in healthcare. 
When we initially started to tackle this problem, we focused on provider 
directories, which seem very simple but [they] are actually plaguing the industry 
by creating a lot of manual costs associated with not understanding where 
physicians are practicing and what kind of patients facilities are treating on a 
daily basis. But we did not have all the answers. Bob came from academia, and 
I was not ready to give up when we hit brick walls. So, what we found was that 
there were innovative techniques around data cleansing, processing, and 
imputation that were being developed in academic institutions across the country 
not within computer science programs, but within other disciplines that are not 
necessarily thought of as the places for AI and machine learning innovation. 
We partnered with Dr. Lars Hernquist at Harvard. He founded the Harvard-
Smithsonian Center for Astrophysics, and he works on the largest 
supercomputers in the world, modeling galaxy formation from the Big Bang 
forward. He also works on a budget that would be considered less than a 
shoestring in the capitol. So, they have had to innovate ways to process data 
quickly, accurately, and in a cost-efficient way. He helped us learn and look at 
research that was happening in the academic space and bring that innovation into 
industries so that we could deliver our products at a price point where customers 
would be successful. 
We also partnered with other scientists. Dr. Sara Walker came out of the 
Beyond Center, and she also teaches at the Santa Fe Institute. She is a complex 
                                                          
 12 What Is an Electronic Health Record (EHR)?, HEALTHIT.GOV (Sept. 10, 2019), 
https://www.healthit.gov/faq/what-electronic-health-record-ehr (defining “Electronic Health 
Record” as a digital version of a patient’s paper chart that provides a “real-time patient-
centered record that makes information available instantly”). 
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systems physicist. She has dealt with the healthcare system personally but had 
no idea that her work could be applied to some of the problems we were facing. 
[Her work focused on] tracking institutional change within systems and how one 
organic change might affect other places within a living system. We applied 
those technologies to changes within the healthcare system to model when 
regulation might impact data. For example, when tax reform passed, there was 
a huge change of providers moving from C corporations to pass-through 
organizations to take advantage of tax reform. That created a data nightmare in 
claims systems across the insurance industry. We could project the most likely 
changes that would happen so that we could deliver better results for our 
customers, and it was based on work that had nothing to do with either computer 
science or healthcare. 
So, we continue this investment in basic research, and it was a radical choice 
as a startup going to our early investors and saying, “We want to have an internal 
lab that funds some basic research and partners with our scientific advisors, but 
we do not want it to have to be tied to healthcare. We do not want it to have to 
be tied to the projects that we are doing. What we want to do is train scientists.” 
So, we see this investment in basic research both at our corporate level and in 
the country, generally, from a government level as a training ground for the 
future innovators, whether they are entrepreneurs or engineers that are building 
this technology. We have been successful. We are currently bringing on a 
Fulbright scholar over the summer that is coming to be a part of our lab. We also 
have one to two-year fellowships where we bring people in partnership with our 
academic institutions in to do research, expose our internal scientists to that type 
of rigor, and then send them back to the academic sector where they can create 
technologies and do research in their fields of origin. Or, we can even inspire 
them to enter industry. 
One of the reasons why we really need them to enter industry is this $3 billion 
paragraph. There is a piece of a regulatory guideline that came down in 2015 
requiring insurance plans to do manual outreach to doctors and hospitals to ask 
them questions about who works there, what kind of patients they see, and about 
the insurance they take. It is an extraordinarily expensive way to curate data. It 
is also not at all effective. By every measure, including measures that come out 
annually from the Centers for Medicare & Medicaid Services (“CMS”), this 
methodology only produces about 50 percent data accuracy on healthcare 
providers across the country. It does not work. It is wildly expensive. But it is 
also stifling innovation. Because of this paragraph, in one legislative notification 
that came out from CMS in 2015, companies have been forced to create solutions 
that are manual. 
We bucked the trend and took a chance. We were lucky that we had investors 
that were willing to back us going against this legislation because we were 
30 THE CATHOLIC UNIVERSITY [Vol. 28.2 
 JOURNAL OF LAW AND TECHNOLOGY 
asking our customers to invest in automated technology that increases their data 
accuracy from 50 percent to 95 percent in the course of a week. But they had to 
do it while still spending money on manual outreach that is ineffective and 
wasteful. And so, one of the challenges for innovators entering regulated 
industries are policies like these that are regulating and mandating methods 
rather than the outcomes that we are trying to achieve. So, one of the things that 
I wanted to bring to everyone here, whether it is from an intellectual property 
perspective or a policy perspective, is that pace of change that Jeffery talked 
about in the beginning, and the pace of adoption will continue to increase. But 
if we have policy and regulation that requires outdated methodology, we are 
going to stifle U.S. innovation while innovators move to other parts of the globe 
that do not have those similar regulations around methodology and that focus 
more on outcomes. 
I have three recommendations that I will leave you with. In order, from an AI 
perspective, to enhance U.S. innovation to incentivize cost-savings, but also to 
create the kind of commercialization from regulated industries that can make the 
economy grow, focusing on results and not methodology is critically important. 
Removing the regulatory hurdles that we talked about and incentivizing cost-
savings [is crucial]. From an intellectual property perspective, there is one thing 
that I would add after listening to everyone here today. So, I know a question 
that I am going to get around AI and intellectual properties will focus on 
algorithmic protections. Well, 80–90 percent of what we do is more traditional 
than that. There are systems that we set up, data processing, data cleansing, some 
hardware components, the way we architect our cloud architecture, all of that is 
very protectable. I do not think we have to have a race to change the intellectual 
property infrastructure to meet AI where it is today. However, I think looking at 
growing the industry as a whole is a good first place to start, because so much 
of what we already do is protectable. The things that are holding us back are 
workforce and regulation. So, if we can lift those barriers, I do not think we are 
going to have an intellectual property problem, I think we are going to have 
flourishing industries here in the U.S. Thank you. 
[Applause.] 
EVERARDO RUIZ: Nice. We had a saying at MIT, “Tell me how I am 
measured, and I will tell you how I will behave.” So, that was interesting 
commentary on something that at first seems like, “Oh it is simple. There is only 
one paragraph of policy [I need to follow].” Well, $3 billion for 50 percent? I 
can flip a coin for free, right? Well done. We now have ten minutes left for 
various questions. So, I will kick it off before everyone else jumps in. 
Everyone has some protectable technology, some of which is just held secrets, 
some of which is patented, it really depends on the industry we are talking about 
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here. There is more and more software and ideas and now, in theory, with the 
internet, it is able to just disappear instantly. Can you talk about trade secrets 
and what advice you would give other innovators for going forward? How do 
you protect trade secrets given that they are just so amorphous? 
MATTHEW BYERS: In our business, it is not really amorphous. What I am 
teaching the different divisions in our company, is that the managers need to 
look around at the processes that they are engaged in, and they will decide what 
they do not want to share with the outside world. They just make a business 
decision. Then, since it is a trade secret, it must be maintained as a secret. If you 
do not maintain it as a secret, it is not a secret and it is not actionable. So again, 
in the manufacturing environment, you put up barriers, you put up signs. You 
just do these things that are practical, but it is a business decision in our world. 
MEGHAN GAFFNEY BUCK: I would say, in our perspective, it is more 
about looking at what qualifies as protectable and what might not [qualify as 
protectable]. It is an investment decision of how we want to spend our dollars. I 
listen to my lawyers when they weigh what is likely to be protectable against 
what we should keep as a trade secret. 
PAUL R. ZIELINSKI: From the federal side of things, we are not really able 
to keep per se a trade secret. I mean proprietary information we can protect, and 
in fact, in that green paper we talk about the ability to maybe extend the period 
of time during which we can protect that information in order for it to reach the 
intended market. But, in the long run, we want to make things available, so trade 
secrets are not really our area. 
G. NAGESH RAO: From my days in the private sector, the rule of thumb I 
would always use with the engineers and our intellectual property counsel was 
if piece of technology could be reverse engineered, then go for the patent. But, 
if it can really be kept a secret, then keep the trade secret. There is a benefit to 
open innovation and there is a benefit to closed innovation. So [our goal was] to 
just understand what particular piece of technology we were working with so as 
to determine the right property right for it. 
PJ BELLOMO: So likewise, a patent would be an exception to the rule: 
seventeen years, mostly software, keep it a trade secret. The reality is, for us 
startup folks, the hardest thing actually is not the engineering. In my experience, 
the hardest thing is sales and marketing and scaling the business. So, you could 
spend all your time trying to get a patent, and in the meantime, someone beats 
you to market. So, it is an exception. 
PROFESSOR NEEL SUKHATME: I will speak from the perspective of my 
startup. We have five issued patents. So obviously, as a patent attorney, I 
recognize the importance of that. But I also recognize that patent law changes 
over time. What might be patentable now may not be patentable in the future. 
You have to diversify your risk, and so, we have been careful to make sure that 
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we have core technologies protected by patent law but also core components that 
are essential to making our business work, protected by a trade secret. So, I think 
there is a notion of diversifying that is important and having both patents and 
trade secrets is a way of dealing with that. 
EVERARDO RUIZ: So we have Neel Sukhatme here from Georgetown, PJ 
Bellomo from Blue Sources, Paul Zielinski at NIST, G. Nagesh Rao over at the 
SBA, Matthew Byers from Zoeller Pump, and Meghan Gaffney Buck from 
VEDA Data Solutions. Please feel free to ask questions. 
MISSIONARY RANGE: Thank you. Hello, I am Missionary Range and I am 
the intellectual property owner of “Black Lives Matter,” “All Lives Matter,” and 
“Blue Lives Matter”; all of that is my work and it was a sermon. So, I am asking 
this question, but it is not based upon my intellectual property. My question 
focuses on Blue Sources and Flint. How is Flint using your technology and have 
there been improvements in the water in Flint, Michigan? 
PJ BELLOMO: Thank you for the question. They are not, but in their defense, 
I will say that the U.S. Army put the technology out years ago. It was the first-
generation technology used in a limited range and our second-generation 
technology has only been available for sixty days. So, we are new to the market 
and no one knows about us. We are trying to land the first few customers and 
then expand either to Flint or any place else. 
But first-generation technology is in use in other cities around the United 
States. As a security technology, it is interesting, [because] people typically do 
not like to tell you what they are using as a defensive mechanism. So, the cities 
that are using this technology, most of them are not advertising that they are 
using it. It is almost like cybersecurity; you do not tell the bad guys what you 
are doing to protect your IT assets. 
MISSIONARY RANGE: Is it lawful for the water not to be clean in Flint? 
PJ BELLOMO: I do not know enough about the Flint situation to speak in 
any type of detail. But, I would love to talk to them if they want to talk to us. 
EVERARDO RUIZ: Other questions? 
DR. CARL J. SCHRAMM: This is for Paul. I read the green paper from cover 
to cover. I have just one question: Has there ever been an honest to goodness 
study of the Innovation Corps (“I-Corps”)13 and its effectiveness? 
PAUL R. ZIELINSKI: I am not aware of one. I know we have questions about 
that ourselves and we have been talking a good bit. I talked about the different 
                                                          
 13 NSF Innovation Corps (I-Corps), NAT’L SCI. FOUND., https://www.nsf.gov/news/ 
special_reports/i-corps/ (last visited May 29, 2020) (explaining that the National Science 
Foundation Innovation Corps (I-Corps) exists to prepare “scientists and engineers to extend 
their focus beyond the university laboratory” to accelerate NSF-funded research projects to 
commercialization). 
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workgroups and some of the ideas behind putting together some level of 
evaluation. I mean the biggest thing that I see reported right now is how many 
teams have gone through the system? However, the real question is, how many 
of those teams have been effective? But I do not have any data like that. 
DR. CARL J. SCHRAMM: Even the premise seems confused. I have heard 
[I-Corps] advertised several times as focused on getting people in the middle of 
their careers with PhDs or PhDs and MDs and taking the career scientist out of 
the laboratory, and apparently America will be better off if we teach them how 
to become entrepreneurs. 
PAUL R. ZIELINSKI: Well, its original start is actually tied back to SBIR. 
So, the original start of I-Corps actually came out of a funding program for 
National Science Foundation (“NSF”), SBIR recipients in order to improve their 
level of success in reaching the marketplace. That is actually where it came from 
and what its origins in terms of funding by the NSF were. Now, it has changed 
a bit since then and there have been many teams. 
G. NAGESH RAO: Yeah, so, there has not been an honest to goodness 
assessment on the I-Corps program yet. That is correct. But I think what is also 
interesting is that it has only been a few years. I-Corps is still in its nascent 
stages. 
DR. CARL J. SCHRAMM: Well, actually, the green paper says it has been in 
place for almost a decade. 
G. NAGESH RAO: Well, it depends. From an NSF perspective, yes. But 
remember, it is an à la carte approach. Every agency that has adopted some I-
Corps-like program has approached it a bit differently, and I think that is one 
thing to keep in mind. Since it came out of the SBIR program and then a number 
of agencies were adopting it, there are a number of different mission needs to 
consider. So, like the SBIR program, there is an à la carte approach. You have 
granting agencies like the Department of Energy, National Science Foundation, 
Health and Human Services where the technology commercialization pathway 
to success is just to get the technology out to the market; that is their mission at 
the end of the day. They just want it out there for the good of the public. Whereas 
with agencies like the Department of Defense and NASA, they do not operate 
on a granting perspective for the SBIR; it is contracting. The reason why is 
because at the end of the day, Defense and NASA, they are looking to acquire 
that technology; it is an acquisition perspective. And so, it also creates a 
delineation with the small businesses. Do you wish to be a high-tech small 
business company? Maybe the contracting vehicle is the way to go. Do you wish 
to be a startup that actually scales up and grows? Maybe the granting [vehicle is 
more appropriate]. There is that delineation. Not every startup is going to be a 
small business, not every small business is going to be a startup. But having 
that à la carte, diverse approach and enabling that across the American economy 
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has proven to be pretty successful so far. Now, it is going to be interesting as we 
become more globalized economically and with the other countries’ approaches 
to this effort. But the one way I think the U.S. has stayed on top from that 
perspective is by maintaining its non-dilutive stature and not taking equity. I see 
Singapore doing it, I see Taiwan doing it. I advised Sri Lanka and Vietnam on 
that perspective when I was an Eisenhower Fellow back in 2016. They both took 
my option, chose not to take an equity stake, and allowed the free market to play 
because, at the end of the day, the free market is democratic in nature. 
EVERARDO RUIZ: I wish we had more time. We could go on for hours on 
these topics and as we can see it is all very nuanced. Let us thank the speakers 
for what we have established with respect to what is currently happening and 
then we will talk about the next five years with the next panel of speakers. 
[Applause.] 
AMI PATEL SHAH: Good afternoon everyone. We are going to get started 
with our afternoon panel. It is about the next five years and where we are going. 
For those of you that are here to learn about case law, 101, PTAB, you are at the 
wrong meeting. This is more about thinking at a macro-level about where our 
country is going and where it needs to go; it is not looking at the micro-level. I 
would like to focus our question and answer portion, our agenda, and where we 
want to go at the macro-level so that our country moves forward in the next five 
years and, hopefully, the people on this panel and those in the audience will then 
work at the micro-level to get us there. I hope to have a very fruitful dialogue 
amongst us. 
The second panel is going to involve questions, comments, and disagreements 
on how we are going to move forward. I want to get started with how digital 
innovation is giving rise to new business models. However, as the previous panel 
has explained, regulations are not keeping up quickly enough with the 
technological changes that we are seeing in the industry. So, what we want to 
focus on in the next few hours is: what are policymakers and regulators to do, 
and how will we get there to ensure that our country moves forward in the next 
five years and keeps its lead in innovation? 
I want to start with a Forbes article that recently talked about the new digital 
era, the post-digital era that talks about the new technologies that are coming to 
the forefront, including blockchain, AI, augmented reality, virtual reality, 
quantum computing and on and on. There are plenty of technologies. What are 
we doing based on patent law? How is patent law keeping up with this post-
digital era? If you really deep dive and look at what those four technologies are, 
they are pretty much software, data, and computer-driven. So, what are we doing 
to keep up with that in the law and what are the companies doing? I want to start 
out with Patrick Kilbride. What is the Chamber of Commerce doing and what 
